Case study reports a suspected dapagliflozin-induced liver injury, suggesting careful monitoring for hepatotoxicity in diabetes patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alawadhi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: